DNA vaccine encoding the major virulence factors of Shiga toxin type 2e (Stx2e)-expressing Escherichia coli induces protection in mice

Vaccine

Volumn 31, Issue 2, 2013, Pages 367-372

  Ren, Wenkai ^a,c   Yu, Rui ^b   Liu, Gang ^a,d   Li, Nengzhang ^c   Peng, Yuanyi ^c   Wu, Miaomiao ^a   Yin, Yulong ^a   Li, Yinghui ^a   Fatufe, Andrew A ^a   Li, Teijun ^a  

^a AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^b BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^c SOUTHWEST UNIVERSITY   (China)

^d INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

Edema disease; Escherichia coli; FedF; Stx2eB

Indexed keywords

C REACTIVE PROTEIN; DNA VACCINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; SHIGA TOXIN TYPE 2E; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VEROTOXIN 2; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; EDEMA DISEASE OF SWINE; ENZYME ACTIVITY; EXPERIMENTAL MODEL; FEMALE; FIMBRIA; IMMUNIZATION; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTECTION; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES; BACTERIAL VACCINES; C-REACTIVE PROTEIN; CELL LINE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; HEK293 CELLS; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; RANDOM ALLOCATION; SHIGA TOXIN 2; SWINE; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, DNA; VIRULENCE FACTORS;

EID: 84871389813     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.107     Document Type: Article

References (41)

1. Tiels P., Verdonck F., Coddens A., Goddeeris B., Cox E. The excretion of F18+ E. coli is reduced after oral immunisation of pigs with a FedF and F4 fimbriae conjugate. Vaccine 2008, 26(17):2154-2163.
2. Nagy B., Whipp S.C., Imberechts H., Bertschinger H.U., Dean-Nystrom E.A., Casey T.A., et al. Biological relationship between F18ab and F18ac fimbriae of enterotoxigenic and verotoxigenic Escherichia coli from weaned pigs with oedema disease or diarrhoea. Microb Pathog 1997, 22(1):1-11.
3. Cheng D., Sun H., Xu J., Gao S. Prevalence of fimbial colonization factors F18ab and F18ac in Escherichia coli isolates from weaned piglets with edema and/or diarrhea in China. Vet Microbiol 2005, 110(1-2):35-39.
4. Imberechts H., Bertschinger H.U., Stamm M., Sydler T., Pohl P., De Greve H., et al. Prevalence of F107 fimbriae on Escherichia coli isolated from pigs with oedema disease or postweaning diarrhoea. Vet Microbiol 1994, 40(3-4):219-230.
5. Tiels P., Verdonck F., Coddens A., Ameloot P., Goddeeris B., Cox E. Monoclonal antibodies reveal a weak interaction between the F18 fimbrial adhesin FedF and the major subunit FedA. Vet Microbiol 2007, 119(2-4):115-120.
6. Tiels P., Verdonck F., Smet A., Goddeeris B., Cox E. The F18 fimbrial adhesin FedF is highly conserved among F18+ Escherichia coli isolates. Vet Microbiol 2005, 110(3-4):277-283.
7. Smeds A., Pertovaara M., Timonen T., Pohjanvirta T., Pelkonen S., Palva A. Mapping the binding domain of the F18 fimbrial adhesin. Infect Immun 2003, 71(4):2163-2172.
8. Imberechts H., De Greve H., Schlicker C., Bouchet H., Pohl P., Charlier G., et al. Characterization of F107 fimbriae of Escherichia coli 107/86, which causes edema disease in pigs, and nucleotide sequence of the F107 major fimbrial subunit gene, fedA. Infect Immun 1992, 60(5):1963-1971.
9. Smeds A., Hemmann K., Jakava-Viljanen M., Pelkonen S., Imberechts H., Palva A. Characterization of the adhesin of Escherichia coli F18 fimbriae. Infect Immun 2001, 69(12):7941-7945.
10. Imberechts H., Wild P., Charlier G., De Greve H., Lintermans P., Pohl P. Characterization of F18 fimbrial genes fedE and fedF involved in adhesion and length of enterotoxemic Escherichia coli strain 107/86. Microb Pathog 1996, 21(3):183-192.
11. O'Loughlin E.V., Robins-Browne R.M. Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells. Microbes Infect 2001, 3(6):493-507.
12. Waddell T.E., Lingwood C.A., Gyles C.L. Interaction of verotoxin 2e with pig intestine. Infect Immun 1996, 64(5):1714-1719.
13. Mainil J. Shiga/verocytotoxins and Shiga/verotoxigenic Escherichia coli in animals. Vet Res 1999, 30(2-3):235-257.
14. Ran X.Q., Wang H.Z., Liu J.J., Li S., Wang J.F. The immunogenicity of fusion protein linking the carboxyl terminus of the B subunit of Shiga toxin 2 to the B subunit of E. coli heat-labile enterotoxin. Vet Microbiol 2008, 127(1-2):209-215.
15. Bosworth B.T., Samuel J.E., Moon H.W., O'Brien A.D., Gordon V.M., Whipp S.C. Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine. Infect Immun 1996, 64(1):55-60.
16. Creydt V.P., Miyakawa M.F., Martin F., Zotta E., Silberstein C., Ibarra C. The Shiga toxin 2 B subunit inhibits net fluid absorption in human colon and elicits fluid accumulation in rat colon loops. Braz J Med Biol Res 2004, 37(6):799-808.
17. Johansen M., Andresen L.O., Jorsal S.E., Thomsen L.K., Waddell T.E., Gyles C.L. Prevention of edema disease in pigs by vaccination with verotoxin 2e toxoid. Can J Vet Res 1997, 61(4):280-285.
18. Liu G.P., Wu B., Lin Y.Y., Jin M.L., Chen H.C. Expression of GST-3B fusion protein of Escherichia coli of Ee strain producing SLT-IIe toxin and study on its biological activities and immunogenicity. Wei Sheng Wu Xue Bao 2007, 47(4):686-691.
19. Oanh T.K., Nguyen V.K., De Greve H., Goddeeris B.M. Protection of piglets against edema disease by maternal immunization with Stx2e toxoid. Infect Immun 2012, 80(1):469-473.
20. Zhao Z., Xu Y., Wu B., Cheng X., Li Y., Tang X., et al. Characterization of attenuated Salmonella C500 strain with a delta asd mutant and use as an Asd+balanced-lethal host-vector system. Sheng Wu Gong Cheng Xue Bao 2009, 25(1):29-36.
21. Vogeli P., Bertschinger H.U., Stamm M., Stricker C., Hagger C., Fries R., et al. Genes specifying receptors for F18 fimbriated Escherichia coli, causing oedema disease and postweaning diarrhoea in pigs, map to chromosome 6. Anim Genet 1996, 27(5):321-328.
22. Acheson D.W., De Breucker S.A., Jacewicz M., Lincicome L.L., Donohue-Rolfe A., Kane A.V., et al. Expression and purification of Shiga-like toxin II B subunits. Infect Immun 1995, 63(1):301-308.
23. Marcato P., Griener T.P., Mulvey G.L., Armstrong G.D. Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia. Infect Immun 2005, 73(10):6523-6529.
24. Ch'en P.F., Xu X.G., Liu X.S., Liu Y., Song C.J., Screaton G.R., et al. Characterisation of monoclonal antibodies to the TNF and TNF receptor families. Cell Immunol 2005, 236(1-2):78-85.
25. Dinarello C.A. Interleukin-1. Cytokine Growth Factor Rev 1997, 8(4):253-265.
26. Smyth M.J., Johnstone R.W. Role of TNF in lymphocyte-mediated cytotoxicity. Microsc Res Tech 2000, 50(3):196-208.
27. Szalai A.J. The biological functions of C-reactive protein. Vascul Pharmacol 2002, 39(3):105-107.
28. Szalai A.J., Briles D.E., Volanakis J.E. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol 1995, 155(5):2557-2563.
29. Szalai A.J., VanCott J.L., McGhee J.R., Volanakis J.E., Benjamin W.H. Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice. Infect Immun 2000, 68(10):5652-5656.
30. Edelblum K.L., Turner J.R. The tight junction in inflammatory disease: communication breakdown. Curr Opin Pharmacol 2009, 9(6):715-720.
31. Ishii N. Role of oxidative stress from mitochondria on aging and cancer. Cornea 2007, 26(Suppl. 1 (9)):S3-S9.
32. Al-Gubory K.H., Fowler P.A., Garrel C. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int J Biochem Cell Biol 2010, 42(10):1634-1650.
33. Newsholme P., Haber E.P., Hirabara S.M., Rebelato E.L., Procopio J., Morgan D., et al. Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol 2007, 583(Pt 1):9-24.
34. Kinter M. Analytical technologies for lipid oxidation products analysis. J Chromatogr B Biomed Appl 1995, 671(1-2):223-236.
35. Del Rio D., Stewart A.J., Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005, 15(4):316-328.
36. Zelko I.N., Mariani T.J., Folz R.J. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1) Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 2002, 33(3):337-349.
37. Safiulina V.F., Afzalov R., Khiroug L., Cherubini E., Giniatullin R. Reactive oxygen species mediate the potentiating effects of ATP on GABAergic synaptic transmission in the immature hippocampus. J Biol Chem 2006, 281(33):23464-23470.
38. Kantengwa S., Jornot L., Devenoges C., Nicod L.P. Superoxide anions induce the maturation of human dendritic cells. Am J Respir Crit Care Med 2003, 167(3):431-437.
39. Tan P.H., Sagoo P., Chan C., Yates J.B., Campbell J., Beutelspacher S.C., et al. Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J Immunol 2005, 174(12):7633-7644.
40. Matsue H., Edelbaum D., Shalhevet D., Mizumoto N., Yang C., Mummert M.E., et al. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J Immunol 2003, 171(6):3010-3018.
41. Ren W., Zou L., Li N., Wang Y., Liu G., Peng Y., et al. Dietary arginine supplementation enhances immune responses to inactivated Pasteurella multocida vaccination in mice. Br J Nutr 2012, 1-6. 10.1017/S0007114512002681.